Genentech Inc – ‘S-4/A’ on 9/8/95 – EX-23.2

As of:  Friday, 9/8/95   ·   Accession #:  950123-95-2577   ·   File #:  33-59949

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Pre-Effective Amendment to Registration of Securities Issued in a Business-Combination Transaction   —   Form S-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-4/A       Amendement No.1 to Form S-4                          189   1.10M 
 2: EX-2.2      Agreement, Dated as of July 7, 1995                    7     25K 
 3: EX-2.3      Agreement, Dated as of September 6, 1995              12     40K 
 4: EX-5.1      Opinion of Wachtell, Lipton, Rosen                     2     10K 
 5: EX-8.1      Opinion of Wachtell, Lipton, Rosen                     1      9K 
 6: EX-10.4     Agency Agreement, Dated as of September 6, 1995       12     39K 
 7: EX-10.5     Letter Agreement, Dated September 6, 1995              2     12K 
 8: EX-15.1     Letter Re: Unaudited Interim Financial Information     1      8K 
 9: EX-23.2     Consent of Ernst & Young LLP                           1      8K 
10: EX-23.3     Consent of Price Waterhouse Ag                         1      6K 
11: EX-24.1     Powers of Attorneys                                    1      9K 
12: EX-27.1     Financial Data Schedule                                1     10K 
13: EX-99.1     Form of Proxy for Special Meeting of Stockholders      2±    11K 

EX-23.2   —   Consent of Ernst & Young LLP

EX-23.2
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
                                                                    Exhibit 23.2

CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the Proxy
Statement of Genentech, Inc., which is made a part of Amendment No. 1 to the    
Registration Statement (Form S-4, No. 33-59949) and related Prospectus of       
Genentech, Inc., for the registration of 61,868,803 shares of its Special Common
Stock and to the incorporation by reference therein of our reports dated January
17, 1995, with respect to the consolidated financial statements of Genentech,   
Inc., incorporated by reference in its Annual Report (Form 10-K) for the year   
ended December 31, 1994, and the related financial statement schedule included  
therein, filed with the Securities and Exchange Commission.                     

                                       ERNST & YOUNG LLP

San Jose, California                                                            
September 6, 1995                                                               

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-4/A’ Filing		Date		Other Filings
Filed on:		9/8/95		PRE13E3/A,  PRER14A,  SC 13D/A
		9/6/95
		1/17/95
		12/31/94		10-K,  10-K/A,  11-K,  DEF 14A
				List all Filings